|
Click a field below to see our editors and consultants:
Astronomy/Cosmology
Biochemistry
Cell Biology
Chemistry
Computing
Developmental
Biology
Ecology
Endocrinology
Engineering
Environmental
Sciences
Evolution
& Zoology
Exercise / Sports Med.
Forensics
Genetics
Geology
Immunology
Mathematics
Medical Sciences
Molecular Biology
Neuroscience
Oncology
Parasitology
Pharmacology
Physics
Physiology
Plant Biology /
Botany
Psychology / Behavior
Public Health
Toxicology
Virology
Company Headquarters:
Write Science Right
3556 Tobel Springs Dr.
Las Vegas, NV USA 89219 USA
949.929.2196 [tel]
info@writescienceright.com
|
 |
Editors'
Expertise
Write Science Right has more than 50 talented scientific editors whose combined
expertise spans a broad range of specialties. Click on a discipline name in the
menu to the left to see more information about the Write Science Right editors
with experience in the listed field. If you do not see your precise field, click
on one close to it. If you have any concerns about our ability to edit your
particular field, please contact us to discuss your needs.
|
|
Dr. Ann Power Smith, Write Science Right Founder
Ann received her undergraduate training at University of
California, San Diego, where she majored in animal
physiology & neuroscience. She received her Master’s and
Doctorate degrees from University of California, Irvine in
Biological Sciences in the Dept. of Neurobiology & Behavior.
She then worked as a postdoctoral fellow at the Reeve-Irvine
Research Center in the Dept. of Anatomy & Neurobiology for
five years. She has been awarded several research
fellowships, including a Cota-Robles graduate fellowship, a
Steinhaus graduate fellowship, a postdoctoral NRSA from the
NIH, as well as teaching and research paper awards. She has
a broad knowledge of biological sciences, with particular
emphasis in Neuroscience. Her research experience includes
the following specific expertise: animal disease models,
stereotaxic surgery, immunohistochemistry, in situ
hybridization, quantitative analysis of imaging data,
behavioral pharmacology, behavioral assessments,
neurobiology of learning and memory, modulation of memory
consolidation, stress influences on cognition, neuronal
plasticity, interactions among neurotransmitters and
intracellular signaling systems, neuroendocrinology, spinal
cord injury, stem cells, immediate early gene and protein
expression and regulation. Ann is a member of the Council of
Scientific Editors.
Dr. Amy E. Cullinan
Amy Cullinan earned her Bachelor’s degree in Biology at
Oberlin College and her Doctorate of Philosophy from the
Dept. of Medical Microbiology and Immunology at the
University of Wisconsin-Madison. She worked as a
postdoctoral fellow at The Scripps Research Institute, in
the Department of Cell Biology with funding from an NRSA
individual award from NIH. Amy has over 10 years of
biological research experience in immunology, virology,
cancer therapy and infectious disease. Her areas of
expertise include genotyping, methylation analysis, DNA and
RNA viruses, virus-based gene therapy, virus-based
nanoparticles, tumor targeting and treatment,
immunosuppression and immunotherapy, and bacterial, fungal
and parasitic human pathogens and associated diseases. Amy
works as a technical writer and consultant for a specialized
scientific product and service provider.
Dr. Annabelle (Mimi) M. Belcher
Dr. Belcher graduated from Loyola University in New Orleans
with a Bachelor of Arts in Psychology. Prior to commencing
her PhD, she was a pre-doctoral Intramural Research Training
Award fellow at the National Institutes of Health within the
Laboratory of Neuropsychology. Under the direction of
Mortimer Mishkin, she developed a spatial memory task for
use with non-human primates, investigating the effects of
selective hippocampal lesions on task performance in rhesus
macaques. After completing her pre-doctoral fellowship at
the NIH, she received her PhD in Biological Sciences from
the University of California, Irvine in the Department of
Neurobiology and Behavior. Her doctoral dissertation
investigated the enduring behavioral and functional sequelae
of neurotoxic administrations of methamphetamine in a rodent
model of drug use. Dr. Belcher has extensive experience with
animal models of brain injury and drug addiction, and has
published numerous peer-reviewed articles in scientific
journals. She has also served as a reviewer for several
journals. Currently, Dr. Belcher is a post-doctoral fellow
with the Law and Neuroscience Project, a $10M initiative
funded by the MacArthur Foundation with an overarching goal
of defining issues that lie at the intersection of law and
neuroscience.
Her knowledge of techniques includes radioligand binding
assays, immunocytochemistry, pharmacology, histology, animal
models of drug addiction, stereotactic surgery, microscopy,
excitotoxic lesions in non-human primates, neuroprotective
mechanisms, MRI-based evaluation of brain damage, cognitive
flexibility, and neurolaw.
Dr. Ben Mathiesen
Ben graduated from Brown University with a Bachelor of
Science degree in physics, earning Phi Beta Kappa and Sigma
Xi honors. Ben received his Master’s and Doctorate degrees
from the University of Michigan. He is a research
astrophysicist specializing in X-ray astronomy, the
numerical simulation of astrophysical fluids, and the
evolution of the universe. In addition to writing and
publishing numerous journal articles in astronomy and
astrophysics, he has designed and taught several courses in
physics, applied math, technical writing, and scientific
programming. An American living in Paris, Ben speaks French
fluently and been doing freelance work as a science writer,
editor, and translator since 1996. Ben can edit papers in
any branch of physics (including but not limited to
relativity, cosmology, fluid dymanics, quantum mechanics,
optics, waves, nuclear & plasma physics & biophysics), and
has also edited papers in the fields of engineering,
computer science, mathematics, economics, geology, and
chemistry.
Dr. Candace Y. Hsieh
Candace received her Bachelor’s degree from the University
of California, San Diego, where she majored in Cognitive
Science with a specialization in Neuroscience. She received
her Master’s and Doctorate degrees from the University of
California, Irvine in Biological Sciences. She currently
works in the Department of Neurobiology & Behavior at the
same institution. She has been awarded several research
fellowships, including a postdoctoral NRSA from NIH and the
University of California President’s Postdoctoral
Fellowship. She has a broad knowledge of the biological
sciences, with a strong emphasis on Neuroscience. Her lines
of research experience include the following areas of
expertise: behavioral pharmacology, electroencephalography
in non-human primates, in vitro extracellular and
intracellular (whole cell patch) electrophysiology, effects
of neuromodulators on neurotransmitter release, animal
disease models, in situ hybridization, immunohistochemistry,
stereotaxic surgery, sensory system physiology and anatomy,
2-photon calcium imaging in acute slices, in vitro
electroporation, neuroanatomical labeling, confocal
microscopy, molecular mechanisms of circuit formation, roles
of receptor tyrosine kinases in axon guidance and
developmental neuroanatomy.
Dr. Caren Smith
Caren Smith received her Bachelor of Science degree in
biochemistry from California State University, Fullerton and
her doctorate from The Scripps Research Institute in La
Jolla, CA. Her graduate work was in the field of synthetic
zinc finger protein transcription factors with additional,
specialized training in eukaryotic gene transcription at
Cold Spring Harbor laboratories. Caren received a
postdoctoral fellowship from the American Heart Association
for the study of ischemic stroke models and VEGF/Src
signaling. Dr. Smith has published in peer-reviewed journals
over the past 10 years. Caren has expertise in library
construction and phage display selection, synthetic zinc
finger protein assembly, promoter cloning, protein
purification, DNaseI footprinting, retroviral and lentiviral
production,in vivo tumor models, ischemic stroke models,
shRNA expression, intracranial/intravenous growth factor
studies, blood-brain barrier integrity, confocal microscopy,
and protein expression of signaling pathways. She has also
edited successfully funded R21, RO1, and center grants.
Dr. Carol Wenzel
Carol Wenzel received her BSc and MSc in Biology from
Carleton University in Canada, and her PhD in Plant Biology
from the Australian National University. She is currently
doing post-doctoral research on the genetic and hormonal
basis of plant vascular development. She has a broad
research experience including studies on the developmental
cell biology of plant vascular development, and leaf and
root formation. Her areas of expertise include plant
biology, hormone physiology, cell cycle and cytoskeletal
cell biology, anatomy, microscopy, genetics, and molecular
biology.
Expertise pages to be included on:
Dr. Catherine Neary
Dr. Neary received her PhD from Thomas Jefferson University,
where she worked in the laboratory of Dr. John Farber on
cytoskeletal damage in an Alzheimer’s model as well as the
intrinsic pathway of apoptosis. She was then hired a
postdoctoral fellow in the Cellular Biochemistry Section
(CBS) of the Center for Cancer Research. The CBS, lead by
Dr. Yoon Sang Cho-Chung, studied all aspects of
tumorigenesis related to the cAMP-dependent protein kinase (PKA).
Using confocal microscopy, Dr. Neary showed that
overexpression of the an RII subunit results in its
translocation to the cell nucleus. Together with previous
work in the laboratory, her work suggests that, in cells
with high levels of RII, this subunit of PKA may be
responsible for initiating expression of genes whose protein
products are important for differentiation of the cell. This
data can be used in support of clinical trials in cancer
patients whose tumor cells overexpress RI, with the aim of
inducing cancer cells to redifferentiate and revert to
non-cancerous phenotypes. Dr. Neary continued her work in
cell death with a project examining the consequences of
calcium dysregulation secondary to compromised endoplasmic
reticulum function at the National University of Ireland,
Galway, in the National Centre for Biomedical and
Engineering Sciences. She currently works at the University
of Medicine and Dentistry of New Jersey on hypoxic injury to
mitochondria in neonatal heart cells.
Dr. Chris Tachibana
Dr. Chris Tachibana graduated from Whitman College and
Cornell University, and received her Ph.D from the Institute
of Molecular Biology, University of Oregon. She has worked
as a researcher at Fred Hutchinson Cancer Research Center in
Seattle, and at Carlsberg Research Center and Copenhagen
University in Denmark. As an instructor and guest scientist
at Penn State University, she taught general biology,
genetics, biochemistry, human biology, microbiology,
virology, and molecular and cell biology. Currently, she is
a senior scientist and instructor at the University of
Washington in Seattle, working on transcriptional control of
stress-regulated genes. Her science writing experience
includes case studies for Annenberg Media's "Rediscovering
Biology" website, and feature articles for life science
industry publications. Her research expertise includes
eukaryotic genetics and cell biology, protein folding and
cellular redox reactions, and regulation of gene expression.
Dr. Danielle A. Simmons
Dr. Danielle Simmons received her Bachelor’s degrees from
Rutgers University in New Brunswick, New Jersey, where she
majored in Biology and Psychology. She received her PhD in
Biological Sciences from the University of California,
Irvine (UCI) at the Department of Neurobiology and Behavior
with an emphasis on neuroendocrinology and reproductive
behavior. Dr. Simmons worked as a Assistant Researcher for 7
years in the Department of Psychiatry and Human Behavior at
UCI studying neurodegenerative diseases such as
Huntington’s, Alzheimer’s and Niemann-Pick Type C with
particular emphasis on the role of the loss of neurotrophic
support on disease progression. Currently, Dr. Simmons is a
Senior Research Scientist at Stanford University and is
continuing to develop neurotrophin-based therapeutics for
Huntington's and Alzheimer's disease. She also worked at
Cortex Pharmaceuticals performing behavioral studies of
learning and memory and was the Program Manager for Drug
Development at Thuris Corporation focusing on developing
therapeutics for the aforementioned disorders. She has 14
years of experience in academic laboratories and 4 in
biotechnology with particular expertise in the areas of
neuroanatomy, neuroendocrinology, reproductive physiology,
neurobiology of learning and memory, neuroinflammation and
neurodegeneration. Her knowledge of techniques includes
immunocytochemistry and other histological procedures,
genotyping, organotypic slice culture, animal models of
neurodegenerative diseases, behavioral models (motor and
learning and memory), stereotaxic surgery, excitotoxic
lesions, cannula implantation, hormonal manipulations, in
situ hybridization, ELISA, RT-PCR, and Western
immunoblotting.
Dr. David Hill-Eubanks
David Hill-Eubanks received his Bachelor’s degree in Biology
from Rice University, where he followed an interdisciplinary
curriculum that emphasized ecology, evolution, and
environmental science. His subsequent work, leading to a
Doctorate of Philosophy in Pharmacology at the University of
Vermont, included studies on coagulation factor biochemistry
and enzymology, G protein-coupled receptor biology and
pharmacology, and cancer biology. He also played a role in
developing the enabling technology for a biotech start-up
that would become a NASDAQ-traded pharmaceutical company.
His current work focuses on the role of calcium-dependent
transcription factors in the regulation of smooth muscle
physiology. He is coauthor of more than two-dozen
publications in peer-reviewed journals, and has served as
principle editor/co-writer on numerous successful NIH grant
proposals with a total value of more than five million
dollars.
Dr. David Pillard
David Pillard received his undergraduate training at Central
College in Pella, IA, where he majored in biology. He
completed is Master of Science degree at Western Illinois
University, Macomb, working on ecological investigations on
the Mississippi River. David received his doctorate at the
University of North Texas, Denton, studying nutrient inputs
predicted trophic levels of a reservoir under construction.
He is currently a Toxicologist and Program Manager with ENSR,
and is the Technical Director of the company's Toxicology
Laboratory. He is a Certified Senior Ecologist and has
participated in a variety of projects investigating the
potential environmental impact of physical and chemical
perturbations, including: toxicity of road and airplane
deicer chemicals, impacts of a major marine oil spill on
pelagic and benthic organisms, effects of ion imbalances in
freshwater and marine systems, and development of long-term
toxicity test protocols for emergent macrophytes. Dr.
Pillard has published numerous articles in peer-reviewed
scientific journals and several book chapters on various
aspects of environmental toxicology.
Dr. Elizabeth Bless
Liz earned her Bachelor’s degree at Colby College where she
majored in Psychology with a concentration in French. She
spent 3 years post graduation working at Massachusetts
General Hospital in the Psychopharmacology Department as
part of a clinical research team investigating biological
correlates of depression. She then received her Master’s
degree in Biological Psychology from Northeastern University
where her thesis centered on the involvement of the opioid
system in feeding behavior. She continued on to receive her
Doctorate in Neuroscience from Boston College where she
studied the effects of ovarian hormones on mesolimbic
dopamine. Dr. Bless subsequently worked as a post doctoral
fellow at the Eunice Kennedy Shriver Center where she was
awarded an NRSA postdoctoral fellowship for her work on the
chemokinetics involved in the development of the
gonadotropin-releasing hormone system. In addition she
collaborated with a neighboring laboratory in the
investigation of chemoattractants and chemorepellents
involved in neuronal migration. Liz’s experience also
includes 5 years in the biotech industry in drug development
in the area of stroke research. Her technical and research
expertise include stereotaxic surgery, neuroanatomy,
motivation and reward, behavioral analysis,
neuroendocrinology, chronoamperometry, brain stimulation
reward, MCAO surgery, learning and memory, video microscopy,
confocal microscopy, developmental biology, statistical
analysis, immunohistochemistry, cell culture, tissue
culture, neuroprotection, real-time PCR, protein analysis
and developmental neurobiology.
Dr. Elizabeth Caldwell
Elizabeth received her Bachelor’s degree in Microbiology
from California State University and Master’s degree in
Radiation Biology and Health Physics from Colorado State
University with an emphasis on radiation ecology. Her PhD
was awarded in Environmental Toxicology and Ecology from the
University of Tennessee. She has over 25 years of experience
ranging from neuroendicrine system research conducted at the
Salk Institute for Biological Studies to studies of the fate
and transport of heavy metals and radionuclides at Oak Ridge
National Laboratory in Tennessee under an NIH grant. Dr.
Caldwell’s broad knowledge and experience include a
specialization in biological effects of radiation on humans
and terrestrial and aquatic organisms, dose reconstruction,
food chain modeling, and regulatory components of
environmental contamination and cleanup. Other areas of
research and experience include virology, plant physiology,
public health, epidemiology, risk assessment, and
environmental communication and planning. She has written
many technical documents, including USEPA drinking water
criteria documents, as well as articles published in trade
journals and consumer magazines.
Dr. Eric Brown
Eric L. Brown received his undergraduate degree in Biology
from Texas A&M University. He received his Ph.D. in
Immunology from the University of Texas Graduate School of
Biomedical Sciences in Houston, TX. His graduate work
focused on the immunosuppressive effects of ultraviolet
radiation on numerous infectious agents including
Schistosoma mansoni, Candida albicans, and Lyme spirochete
Borrelia burgdorferi. During his postdoctoral fellowship at
the Institute of Biosciences and Technology he received two
grants from the Centers of Disease control to study
mechanisms of bacterial attachment to host matrix components
and for the development of a second generation Lyme vaccine,
respectively. He is currently an Assistant Professor of
Infectious Disease and his research projects involve
studying immune evasion strategies employed by S. aureus in
addition to developing vaccination strategies for the
prevention of diseases caused by this organism. In addition
to publishing various peer-reviewed papers, his areas of
expertise include recombinant protein technology, cell
biology, molecular biology, immunology, vaccine design, and
animal models of infectious disease. He also teaches
Parasitology and Medical Microbiology and is listed as a
co-inventor on three U.S. and international patents.
Dr. Eric Codner
Eric Codner completed Bachelor’s Degrees in Biochemistry and
Chemistry, and then went on to complete his PhD in 2001 in
Analytical and Materials Chemistry at the University of
Minnesota. He has multiple patents in analytical
instrumentation design. His fields of expertise include
analytical chemistry, materials chemistry, surface
chemistry, applied spectroscopy, instrument design, MEMS and
material processing, nanomaterials and sensors. His personal
research endeavors are include instrument design methods as
well as miniature systems for chemical analysis,
multispectral imaging, and satellite propulsion.
Dr. Heidi J. Chial
Dr. Chial received her undergraduate degrees in Chemistry,
Biochemistry, and Molecular Biology from Gustavus Adolphus
College. She earned her Ph.D. degree from the University of
Colorado at Boulder in the Department of Molecular,
Cellular, and Developmental Biology. Dr. Chial has carried
out postdoctoral research at the Mayo Clinic College of
Medicine, Wake Forest University School of Medicine, and
most recently at Stanford University School of Medicine. She
has more than 13 years of academic research experience. As a
postdoctoral research fellow, she wrote manuscripts and
grants, reviewed manuscripts submitted to top-tier
scientific journals, taught graduate student courses, and
developed an NIH NRSA-funded research program. Dr. Chial has
published numerous scientific research articles in
peer-reviewed journals, and she has received both public and
private funding to support her research. She was also a
student in the Marine Biological Laboratory (MBL) 2005
Summer Neurobiology Course. Dr. Chial was an Assistant
Professor of Biology and Chemistry at St. Olaf College,
where she taught undergraduate lecture and laboratory
courses. She was also a consultant and scientific curator
for the Proteome division of Incyte Genomics. She recently
authored 18 articles for the Nature Publishing Group website
Scitable.com on a variety of topics related to human genetic
diseases and genomics. She is currently a technical
specialist and writer for a biotechnology and pharmaceutical
practice group. Her research experience spans the following
areas of expertise: mammalian and yeast genetics, molecular
biology, protein biochemistry, genetic model systems, cell
biology, fluorescence microscopy, live cell imaging, FRET
microscopy, phosphoinositide-mediated signaling pathways,
cell cycle regulation, chromosome segregation, growth
factor- and neurotrophin-mediated signaling pathways,
molecular neuroscience, neurodegenerative disease, and
cancer biology.
Dr. Ilona J. Miko
Ilona Miko earned her B.A. in Biology from Columbia
University and her PhD in Neural Science from New York
University. Ilona has received competitive funding from
multiple funding agencies, including the Howard Hughes
Medical Institute, Pew Foundation and NIH. She is conversant
in a wide range of biological fields beyond her expertise in
neuroscience, from cell and organismal biology to
environmental systems and epidemiology. Her experience also
includes three years in the biotech industry, where she
worked on animal and in vitro models of neurodegenerative
disease. Ilona’s research involves the effect of serotonin
on sensory processing, and the impact of tyrosine kinase
receptors on brain circuit development and sensory function.
Her specific areas of expertise include the following:
neural circuit development, neuropharmacology, physiology,
tissue culture, development and regulation of glia, electron
microscopy, confocal microscopy, immunohistochemistry,
quantitative neuroanatomy, quantitative image analysis,
immediate early gene expression, PCR, ELISA, column
chromatography, whole-cell in vitro physiology, single unit
in vivo neurophysiology, quantitative analysis of neuronal
spike trains, auditory brainstem response (ABR), stereotaxic
surgery, primate and rodent models of neurodegenerative
disease, knockout mouse models, epidemiological analysis,
and biostatistics.
Dr. Ingrid A. Lobo
Ingrid received her Bachelor of Science and Ph.D. in
Molecular Biology from The University of Texas at Austin.
She has broad expertise in fields of biological sciences,
with greatest depth of experience in molecular biology,
biochemistry, pharmacology, neuroscience and the molecular
basis of diseases. While these are her areas of expertise,
Ingrid is fascinated by a wide range of scientific topics
and is committed to communicating science to others. She
wrote a successful Individual Research Service Award, which
was funded by the National Institutes of Health. Her
publications include numerous peer-reviewed articles,
chapters and reviews on the actions of drugs on the nervous
system. Ingrid contributed nineteen articles on genetics to
Nature Education’s Scitable website on a range of subjects,
including genetic recombination, cancer cytogenetics,
genomic imprinting and biological complexity. She has
written for a variety of audiences, from students to
researchers and clinicians. Ingrid has also written and
published a book on inhalant and solvent abuse for young
adults, titled "Inhalants," which is part of a series of
books called "Drugs: The Straight Facts."
Dr. James Marti
James Marti has earned a Ph.D. in Physics from the
University of Minnesota, a Master’s degree in Atmospheric
Science from the University of Arizona, and Bachelor’s
degrees in Physics, Biology, and Environmental Studies from
Macalester College. His doctoral and post-doctoral research
dealt with the physics and physical chemistry of atmospheric
particles, applied to problems of stratospheric ozone
depletion and global climate change. After a position at a
national research laboratory performing computer modeling of
atmospheric particle dynamics, Dr. Marti moved to the
private sector where he has researched the properties of
particulate materials, developed new particle-based
products, and managed the development of analytical
instrumentation. Dr. Marti has published numerous papers in
scientific journals, several articles on science and
technology for the popular press, and has served as an
editor for a journal of the American Geophysical Union.
Dr. Jennie Close
Jennie received her undergraduate degree in Biology and
Chemistry from Whitman College, and was awarded Phi Beta
Kappa and Cum Laude honors. She then received a PhD in
Neurobiology and Behavior from the University of Washington
in 2005 with a thesis exploring the development and stem
cell properties of retinal glia. Currently she is a
postdoctoral fellow in the laboratory of Dr. Gord Fishell at
New York University Medical Center. Her project there
focuses on the molecular mechanisms and timing of inhibitory
interneuron differentiation in the cortex and olfactory
bulb. She is funded by an NRSA through the NIH. Her areas of
expertise include neurobiology, molecular biology,
transcriptional regulation, genetics, stem cell biology, and
developmental biology. She has co-authored numerous
peer-reviewed papers, reviews, grants and book chapters.
Dr. Jennifer Piehl
Dr. Jennifer Piehl received her BA with honors in
Anthropology and German from the University of California at
Berkeley, and her Doctorate in Anthropology from Tulane
University in New Orleans. She specializes in the
archaeology and human osteology of the ancient Maya, and has
conducted research in Honduras, Guatemala and Belize. Her
investigation of community integration, social inequality,
and ancient patterns of health and disease constitutes a
multidisciplinary focus combining social, biological and
medical sciences. Dr. Piehl has also worked on the ancient
populations of West Texas, as the first Physical
Anthropologist and Archaeologist on the staff of the Center
for Big Bend Studies at Sul Ross State University. This
research, like her research on Mesoamerican populations,
combines study of mortuary behaviors, paleopathology, ethnic
identity and social stratification. Such investigations
analyze the indicators of health and cultural practices that
differentiate subgroups of individuals within and between
prehistoric communities. Dr. Piehl’s research incorporates
the use of and contribution to the literature in medical
pathologies, aging processes in humans, anthropology, and
isotopic chemical analysis. She has direct experience in
archaeological fieldwork, computer mapping and GPS
applications, laboratory analysis of forensic and
prehistoric skeletal materials, the study of disease in
prehistoric populations, and stable isotope analysis. She is
currently the Director of the El Peru-Waka’ Archaeological
Project, working in Guatemala’s Laguna del Tigre National
Park, and the Bioarchaeologist for the Baking Pot project
under the Institute of Archaeology in Belize.
Dr. Johanna (Hanna) Craig
Hanna holds graduate degrees from Texas A&M University in
wildlife and fisheries biology, phylogenetic systematics and
molecular toxicology, as well as post-doctoral fellowships
in neuroendocrinology and bioinformatics at the Vollum and
Virginia Bioinformatics Institutes, respectively. Hanna
writes, edits, copyedits, and proofreads scientific
manuscripts for publication, grant proposals and
dissertations and theses. She has written several
award-winning grants, garnering $1.5 million. She has
authored numerous highly technical publications, has an
in-depth understanding of the traditional and latest
biochemical and molecular biology techniques and
applications, and has worked extensively with animal models.
Hanna has conducted microarray studies over a broad range of
species and cell culture systems, as well as pathogen/host
relationship investigations. Additional experience fields
include: molecular biology, neuroscience, oncology,
virology, infectious diseases, pathogenesis, pharmacology,
psychology, physiology, plant science, immunology,
nutrition, aquaculture, clinical trials, development,
endocrinology, genetics, public health, transcription
regulation (chromatin, epigenetic, promoter binding),
translation regulation, signal transduction, cell cycle,
protein structure biology, computational biology, scientific
advisory, disease database design, database curation &
annotation, and statistical design & analysis.
Dr. Joanna Schultz
Joanna Schultz earned her Master’s degree in Environmental
and Systematic Biology from California Polytechnic State
University, San Luis Obispo and her PhD from Washington
State University in Botany. Joanna served as a tenured
Professor of Botany at Lewis-Clark State College for 12
years before entering the private industry. She is currently
a Senior Consultant for Earth Information Systems, where she
is able to dedicate herself full-time to conservation
efforts. Her areas of expertise include evolution,
morphologic and molecular systematics, conservation biology,
ecology, environmental science, including natural resource
management, geospatial/geographic information system
implementation and statistical analyses. Joanna has procured
over $2 million in grant awards and has published in peer
reviewed journals, authored numerous technical reports and
served as a reviewer for scientific journals. Her past and
present research program includes both traditional and
contemporary approaches in the study of evolutionary pattern
and process, including phylogenetic reconstruction,
speciation, population genetics and evolutionary ecology.
Joanna’s most recent research is directed toward natural
resource management, particularly in regards to special
status species. Her work is conducted with a strong emphasis
on quantitative methodologies.
Dr. Joseph Zeni
Joseph has a diverse background in multiple medical and
scientific disciplines. He holds his Bachelor's of Science
in Health Science and his Master's degree in Physical
Therapy. After working in the clinical field for 3 years, he
returned to school to pursue his doctorate in the
interdisciplinary field of Biomechanics at the University of
Delaware. He has collaborated with successful senior
investigators in the fields of Mechanical Engineering,
Rehabilitation, Physiology and Biology and has written
grants that were successfully funded by the NIH. Dr. Zeni is
the first author on eleven manuscripts that are published or
are under review at peer-reviewed journals and is secondary
author on many more. He has presented the findings of his
research at national and international meetings and
currently serves as a reviewer for various peer-review
journals. Joseph is a member of the American Medical
Writer's Association, has experience as a freelance editor
of scientific documents and works well with persons that are
not native English speakers. Joseph completed his
post-doctoral work and recently accepted a position as an
Assistant Professor at the University of Delaware where he
will continue with interdisciplinary and translational
research in the fields of biology, engineering and
rehabilitation.
Dr. Karen Norrgard
After completing her undergraduate degree at the College of
William and Mary, Karen entered graduate school in the
Department of Human Genetics at Virginia Commonwealth
University. Her graduate advisor had previously described an
autosomal recessive disorder called Biotinidase Deficiency,
which is now part of the newborn screening panel (commonly
known as the PKU test). Karen’s work then characterized
mutations in the biotinidase gene of children ascertained by
newborn screening. She also used a baculovirus system to
express different forms of the protein in order to examine
two possible leader peptides of the secreted enzyme. After
receiving her PhD, she worked at Commonwealth
Biotechnologies, Inc., developing PCR-based assays for the
detection of various organisms and managing the company's
DNA sequencing projects laboratory for two years. She moved
into the Reference and Identification laboratory at the same
institution, supervising the laboratory’s output of
paternity tests and maintaining the laboratory’s QA/QC
requirements for court-admissible results.
Dr. Kate Fox
Kate completed a PhD in microbiology at the University of
Oxford, investigating novel phase variable LPS biosynthetic
genes in Haemophilus influenzae. She then moved to Australia
and spent five years as a postdoctoral researcher at the
University of Queensland. Her postdoctoral studies focused
on the role of DNA methyltransferases in gene regulation in
bacterial pathogens. Other projects included the design and
development of live, attenuated vaccines for veterinary
pathogens. She has many first author publications in
high-ranking journals in the area of microbial pathogenesis
and therefore has extensive first-hand experience of dealing
with journals and their specific requirements. She is now a
full-time academic editor, who has edited hundreds of
manuscripts, and has experience editing manuscripts in a
broad range of biological disciplines.
Dr. Kate Edmondson
Kate received her undergraduate degree in Chemical
Engineering with an emphasis in Biomedical Sciences from
Cornell University, where she graduated cum laude. While an
undergraduate, she was awarded the Merck Science and
Technology Fellowship and subsequently worked as an intern
with this pharmaceutical company. She received her doctorate
in Bioengineering from the University of Pennsylvania, where
she studied the adhesion of neutrophils to P-selectin–coated
surfaces under shear flow, and the dynamics and kinetics of
the P-selectin/PSGL-1 bond. She worked as a postdoctoral
fellow at the University of Pennsylvania School of Medicine,
in the Department of Cell and Developmental Biology, and was
awarded an NRSA to fund her research. Her postdoctoral
research involved the dynamics and structure of fibrin clots
formed under flow, both in vitro and in vivo. During her
postdoctoral tenure, Kathryn worked as an editorial intern
with the Journal of Clinical Investigation, where she
developed a passion for science writing and editing. Kathryn
has performed bench research in drug delivery systems and
organic chemistry, and has co-authored peer-reviewed
scientific research articles and successful grant proposals.
Kathryn’s particular areas of scientific expertise fall into
the general categories of biophysics and bioengineering,
with particular emphasis on cell adhesion and migration,
neutrophil/platelet interactions, cardiovascular systems,
blood coagulation, atherosclerosis, thrombosis and
hemostasis, and fibrinolysis.
Dr. Kathryn Nichol
Dr. Nichol completed a double major in Biology and
Psychology at Georgia Southern University in 1997. Aside
from graduating cum laude in both areas, she participated in
an elite honors curriculae that emphasized writing and
communication. She went on to University of California,
Irvine where she completed a master’s degree in biological
sciences, investigating the pathology of a frontal variant
of dementia. An avid athlete and coach, she changed fields
and completed her doctoral degree in Exercise Physiology,
examining the effects of aerobic exercise on endothelium
dependent cerebrovascular reactivity. With a combined
interest in exercise and neuroscience, Kathryn returned to
University of California, Irvine’s Institute for Brain Aging
& Dementia. She examined effects of exercise on Alzheimer’s
disease pathology, immune function, and cognitive outcomes
in animal models. She has had numerous scholarships and
fellowships, including a Kirschstein NRSA postdoctoral
fellowship from NIH. She was recognized as an outstanding
young researcher by the Texas chapter of American College of
Sports Medicine. Her current research has been featured in
the Society for Neuroscience’s Annual press release packets
for the past two years. She has been an invited speaker at
several national and international conferences. Kathryn
currently works as a medical science liaison. Outside of
academic pursuits, Kathryn has been coaching elite athletics
and fitness for 10 years. Kathryn's fields of expertise
include exercise science, vascular physiology, immunology,
dementia and head injury.
Dr. Kelly Engel
Kelly Bonner Engel earned her Bachelor’s degree in
Biological Sciences with specialties in Marine Biology and
Ecology from Florida Institute of Technology, and her
Masters and PhD in Biology from Boston University with an
emphasis on Physiology, Endocrinology, and Reproduction.
Prior to completing her PhD she gained a wide range of
research experience including ecological analysis, feeding
kinematics of estuarine fish, fish physiology, plant and
soil heavy metal analysis, and wetland surveying. Her
doctoral research focused on identification of male
reproductive impacts as a result of environmental
contaminant exposure using molecular, histological, and
ecological approaches. Kelly has extensive research
experience with traditional and nontraditional animal model
systems, cloning, sequence analysis, molecular techniques,
histology, immunocytochemistry, in situ hybridization, and
microscopy. She is the primary author of two text book
chapters focusing on male reproduction in evolutionarily
distant vertebrates, six research articles, and co-author of
a funded National Sea Grant. She has received accolades for
poster and oral research presentations at national and
international conferences. She is currently a literature
database curator for a large United States government
agency.
Dr. Kristina K. Hansen
Kristina Hansen graduated from Northwestern University with
Bachelor's degrees in Chemistry and the Integrated Science
Program. Kristina received her Doctorate in Organic
Chemistry at the University of California, Berkeley, where
she synthesized protease inhibitors. In addition to her
experience with organic and bioorganic chemistry, she has
experience with solid phase synthesis, synthesis of
organometallic compounds, and enzymatic assays. She worked
at SmithKline Beecham Pharmaceuticals in the Medicinal
Chemistry Department. As a postdoctoral researcher, Kristina
has worked in the fields of pharmacology, microbiology, and
molecular biology investigating proteinase-activated
receptors in mammalian cells, including prostate cancer
cells, and identified proteinases from tissues and
biological fluids as activators of proteinase-activated
receptors in gastrointestinal diseases.
Dr. Kylie O'Brien
Kylie O’Brien received her Bachelor of Science in Chemistry
and Biochemistry from the University of British Columbia,
Canada. She received her Doctorate degree in Chemistry from
the University of Minnesota, where she developed analytical
instrumentation for high-speed measurements of neurochemical
dynamics in the central nervous system. The focus of her
research was examining uptake and release of the putative
neuromodulator D-serine in retinal and cortical tissues. As
a postdoctoral researcher, Kylie developed an implantable
biosensor for measuring hydrogen peroxide levels in the
brain at University College Dublin, Ireland and the National
University of Ireland, Maynooth. Advancing analytical
chemistry techniques to answer biological questions has been
a central theme of her research. Her areas of expertise
include separation science (capillary electrophoresis, HPLC),
analytical instrumentation development, biosensors, cell
culture and CNS tissue preparation, pharmacology and
neuroscience. Kylie currently works supporting new method
transfers in the pharmaceutical industry for a multinational
company in Ireland.
Dr. MaryLynn Zurich
MaryLynn received her BA from Ithaca College in Psychology
and Philosophy in 3½ years, cum laude. She spent the next 12
years in the financial and investment community, eventually
starting her own investment firm, handling only corporate
discretionary accounts. After working with racing greyhounds
for 4 years, MaryLynn entered the University of Florida,
College of Veterinary Medicine, and earned her PhD in
Physiological Sciences with a focus on Toxicology. Her
primary research projects dealt with hepatotoxicants,
including acetaminophen and cocaine. She received part of
her training at the Institute of Toxicology in Schwerzenbach,
Switzerland, where she learned the technique of using
precision-cut liver slices and worked almost exclusively
with transgenic rodents. She then returned to the University
of Florida where she initiated the technique at the Center
for Human and Environmental Toxicology. Upon completion,
MaryLynn founded ZTC Inc., a pharmaceutical toxicology
consulting firm acting to advise, plan, manage and monitor
program and study design for the development of potential
drug candidates. This included preparation and review of
pharmaceutical company IND and NDA submissions prior to FDA
submission, quality assurance review of data and statistical
analyses, and primary literature and position paper
interpretation. Recently MaryLynn has also been editing
medical reports for acute-care hospitals. German is
MaryLynn’s 2nd language, and she enjoys editing for her ESL
friends and colleagues in Europe. Her areas of expertise
include: ESL, medical and/or scientific research, medicine,
scientific papers or articles, simplifying complex topics
into presentations for the general public, translating from
German to English, writing instruction manuals or SOPs, and
assisting with sales or marketing materials.
Dr. Michael J. Grey
Michael Grey received his B. S. in Biochemistry with Honors
from Hofstra University. He earned his Ph. D. with
Distinction from the Department of Biochemistry and
Molecular Biophysics at Columbia University, where he
developed and applied nuclear magnetic resonance methods for
characterizing protein folding and dynamics. He is currently
a postdoctoral research fellow at the Immune Disease
Institute and Harvard Medical School. His research studying
the structural mechanisms of transmembrane signaling by the
epidermal growth factor receptor was awarded a fellowship
from the American Cancer Society. He has coauthored original
research and review articles in peer-reviewed journals and
has contributed to the writing and editing of research and
instrumentation grants that have been awarded over $1
million in funding. His areas of expertise include protein
biophysics, biochemistry, structural biology, signal
transduction, cancer biology, and immunology.
Dr. Natalie Shenker
Natalie Shenker studied medicine at Oxford University, where
she was awarded a First Class degree in Physiological
Sciences and won a Scholarship in Clinical Medicine. Before
entering surgical training she undertook an Honorary
Research Fellowship at the Royal Children’s Hospital in
Melbourne, Australia. The work that arose from this period
has been presented nationally and internationally, and
Natalie has twice won the conference prize for best
presentation. She has published numerous papers herself as
first author. Clinically, Natalie completed her Basic
Surgical Training at St Thomas’ and Great Ormond Street
Hospitals in London. She also demonstrated anatomy at Guy’s
Hospital under the tutelage of Professor Harold Ellis and
Professor Susan Standring, and then became a Member of the
Royal College of Surgeons of England. She proceeded to win
an Academic Clinical Fellowship in Pediatric Surgery based
in Oxford and London, and secured grant money for projects
studying the epidemiological nature of neonatal surgical
disease. After overcoming a period of serious illness that
pre-empted a change in career, she is now training in
Reproductive and Developmental Biology at Imperial College,
London. She also holds qualifications in counselling and
psychotherapy. In terms of editing capability, she has a
full grasp of American English spelling and grammar laws
from her previous schooling in the USA.
Dr. Nicholas D. Morgan
Nicholas Morgan received his undergraduate degree at
Villanova University, where he majored in Astronomy and
Astrophysics and earned Phi Beta Kappa and Phi Kappa Phi
honors. He received his doctorate degree from the
Massachusetts Institute of Technology in Physics for work in
the field of observational cosmology, and has since worked
as a postdoctoral researcher at the Yale Center for
Astronomy and Astrophysics and The Ohio State University
Astronomy Department. His research has focused on
gravitational lenses (rare optical mirages formed by the
gravity of distant galaxies) and their implications for the
age of the Universe, the nature and distribution of dark
matter, and the internal structure of quasar accretion
disks. He also has extensive experience conducting
large-scale digital sky surveys and performing time-series
target monitoring, with over 80 nights observing experience
on research-grade telescopes. Nicholas has authored numerous
articles in astronomy and astrophysics journals, co-authored
successful grant-funded proposals for using the NASA Hubble,
Chandra and Spitzer Space Telescopes, and has served as a
manuscript referee for The Astrophysical Journal.
Dr. Phuong Thi Nguyen Sarkis
Thi Sarkis earned her bachelor’s degree from Brandeis
University in Neuroscience with honors and her PhD from the
Johns Hopkins University School of Public Health in
Molecular Microbiology and Immunology. She has had 13 years
of experience in professional or graduate research in the
biological sciences. During the last 10 years, she has
focused on virology and immunology through HIV-related
research in labs affiliated with Harvard University and
Johns Hopkins University. She has received several
competitive professional or research fellowships and
co-authored a number of papers and grants. Her fields of
expertise include HIV virology, vaccine science, cellular
immunology, and interferon signaling pathways. She is now a
post-doctoral researcher at the Dana Farber Cancer Institute
in the Department of Cancer Immunology and AIDS.
Dr. Raymond Price
Ray Price received his undergraduate training in
Biochemistry at Whitman College a small, liberal arts school
in Washington. He earned a PhD in Pharmacology (with an
emphasis in Neuroscience) from Vanderbilt University, where
he worked on the molecular pharmacology of serotonin
receptor signaling. After graduation, Ray worked for a major
Japanese pharmaceutical company in Japan, where he helped
inform business strategy decisions and represented the
company with outside collaborators and stakeholders, as well
as performing research related to CNS diseases.
Subsequently, Ray joined a small biotech company in
Washington, where he worked on assay development using
primary neuronal cultures, as well as being responsible for
implementing the company’s business and scientific
development programs. He recently joined a startup biotech
company in Europe, where he is looking to continue combining
his scientific technical background with business experience
to “sell the science.” He has worked extensively with
scientists whose native language is not English, and has
experience editing journal manuscripts, grant applications,
and regulatory documents (INDs) for the
pharmaceutical/biotech industry. He was also first author on
an invited review and was PI on two funded small business
research grants (SBIR) from the NIH.
Dr. Renee Demarest
Dr. Demarest received her Ph.D. in Molecular Biology and
Genetics from Temple University School of Medicine in 2005.
Her graduate work consisted of studying cyclin T1 regulation
during primary human T-cell activation. Cyclin T1 is a
cellular factor required for replication of HIV. During this
period she received The Distinguished University Fellowship
and a Predoctoral Traineeship Award from the Department of
Defense Breast Cancer Research Program. Since 2005, Dr.
Demarest has worked as a postdoctoral fellow studying the
role of Notch in leukemogenesis in the laboratory of Dr.
Anthony Capobianco at The Wistar Institute. She is supported
by a fellowship from The National Cancer Institute Training
Program in Basic Cancer Research. Dr. Demarest’s graduate
and post-doctoral training has been primarily in Cancer
Biology, with particular emphasis on cellular signaling. She
is proficient in cellular and mouse models of cancer
biology. Her technological experience includes all major
molecular biology techniques, including Western, Northern
and Southern blot analyses, RT-PCR, Real-Time PCR, miRNA
identification and validation, Immunoprecipitation,
Immunohistochemistry, microarray sample preparation and
analysis, cloning, lentiviral and retroviral vector
construction and infection, Chromatin Immunoprecipitation (ChIP),
and kinase assays. She has extensive experience writing and
peer reviewing manuscripts. Additionally, she has
successfully written NIH R01 grants and numerous
fellowships, and has been extensively trained and
participated in reviewing these applications. Currently, Dr.
Demarest is completing her post-doctoral studies at The
Wistar Institute and is beginning her search for an
independent position.
Dr. Rob Campbell
Rob Campbell studied physiology as an undergraduate at the
University of British Columbia in Vancouver, Canada, where
he proceeded to obtain an M.D. After an internship at St.
Mary's Hospital in Montreal he completed a Ph.D. at the
Ludwig Institute for Cancer Research at McGill University.
He went on to do postdoctoral fellowships at the University
of Washington, University of British Columbia, and the
Howard Hughes Medical Institute at the University of
California, San Diego. Throughout his postgraduate and
postdoctoral training Rob received fellowships from the
Medical Research Council of Canada. His areas of expertise
include: a deep familiarity with developmental biology;
neuroscience (in particular developmental neurobiology);
transgenesis and gene targeting, including the Cre/lox
system; histology and immunocytochemistry; molecular biology
and genetics. He is currently approaching science from a new
perspective as the developer of a number of software
applications designed to help biomedical scientists do their
work in the laboratory.
Dr. Silvia da Costa
Silvia da Costa holds Doctoral and Master’s degrees in
pharmaceutical sciences from the University of Southern
California. She holds bachelor’s degrees in physics,
journalism and French from California State University, Long
Beach and has received numerous research awards, fellowships
and grants. As a postdoctoral researcher, Silvia’s past
projects included examination of cytoskeletal filament
system regulation of membrane traffic in lacrimal gland
acini, as well as the development of an experimental disease
model for Sjogren’s syndrome, specifically investigating
changes in the secretory pathway of lacrimal glands in NOD
mice. Silvia also worked in industry as a research scientist
investigating the efficacy and safety of medicinal plants
for use in therapeutic product development. She is currently
a Senior Scientific Editor for City of Hope, a research
institute specializing in translational and clinical
research in the areas of cancer and diabetes. Silvia works
with researchers in the development and editing of
scientific manuscripts and grant proposals and is also
responsible for the production of technical documents. As a
native speaker of both English and Portuguese, with
additional fluency in French, Spanish and Italian, Silvia
can apply a broad knowledge of multiple languages as she
interprets scientific documents written by scientists who
speak English as a second language.
Dr. Theresa Phillips
Dr. Phillips studied Biochemistry at the University of
Waterloo (Canada) and received a Master’s degree in
Biochemistry and Toxicology from the University of Guelph
(Canada), where she studied genetic mutations caused by
environmental carcinogens. Her background in toxicology lead
to research in soil toxicity during bioremediation, and a
position at Adventus Remediation Technologies, where she
worked as a Project Manager for bench-scale studies in the
bioremediation of contaminated soils. She has field
experience in full-scale site remediation and has worked on
a number of US-EPA-funded projects. With support from
Adventus, she obtained a PhD in Environmental Biology from
the University of Guelph, for her studies on biodegradation
of the chlorinated pesticide, Lindane, by soil
microorganisms. Her post-doctoral studies lead her in a new
direction as a Senior Research Scientist in Applied
Molecular Biology at KAM Biotechnologies in Vancouver
(Canada), where she was awarded an NSERC Industrial Research
Fellowship to study biodesulfurization using genetically
modified microorganisms. While at KAM, Theresa also
participated several biofuels and other bioproducts research
projects. She is currently a Project Manager and
Environmental Consultant at Barenco Inc., where she is
pursuing a P.GeoScientist designation, in addition to
freelance writing as the Biotech Guide for About.com and
owner of ProServe Technologies, a virtual assistant service
for the biotechnology industry.
Dr. Wendy Grus
Dr. Wendy Grus received her undergraduate degrees in Ecology
and Chemistry from the University of Georgia. Wendy studied
the evolution of the vomeronasal system, a vertebrate
smelling system, in the Department of Ecology and
Evolutionary Biology at the University of Michigan, where
she earned her PhD. Her dissertation research focused on
gene family evolution based on genes mined from publicly
available vertegrate whole genome sequence. Additionally,
she has done research on molecular systematics and
population genetics of birds and pseudogene evolution. She
has co-authored peer-reviewed research papers and reviews
for top-tier journals and has shared oral and poster
presentations at the annual meetings for the Society of
Molecular Biology and Evolution, the Association for
Chemoreception Sciences, and the Society for the Study of
Evolution. Earning her PhD from a lab with 80% non-native
English speakers, Wendy has extensive experience editing
scientific manuscripts to improve their English. She is
currently a postdoctoral researcher at the Fred Hutchinson
Cancer Research Center in Seattle, Washington, where she is
trying to understand how differences in orthologous
chemoreceptor sequence (both intra and inter-specific)
translates into differences in chemoreceptor function.
Wendy’s experiences have given her thorough knowledge of
experimental and computational biology tools to study
evolution, comparative genomics, genetics, population
genetics, ecology, and neuroscience.
|
|